Published in
Elsevier, The Lancet, 10075(389), p. 1195-1205
DOI: 10.1016/s0140-6736(16)32616-2
Links
Tools
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Journal article published in 2017 by
David Cameron,
Martine J. Piccart-Gebhart,
Richard D. Gelber,
Marion Procter,
Aron Goldhirsch,
Evandro de Azambuja,
Gilberto Castro,
Michael Untch,
Ian Smith,
Luca Gianni 
,
Jose Baselga,
Nedal Al-Sakaff,
Sabine Lauer,
Eleanor McFadden,
Brian Leyland-Jones
and other authors.
,
Jose Baselga,
Nedal Al-Sakaff,
Sabine Lauer,
Eleanor McFadden,
Brian Leyland-Jones
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 